The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

John J. Parlow

Department of Medicinal Chemistry

Pfizer Global Research & Development

700 Chesterfield Parkway West

Chesterfield

USA

[email]@pfizer.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicinal Chemistry, Pfizer Global Research & Development, 700 Chesterfield Parkway West, Chesterfield, USA. 2005 - 2010
  • Department of Medicinal and Combinatorial Chemistry, Pharmacia Corporation, 800 North Lindbergh Boulevard, St. Louis, USA. 2003

References

  1. Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation. Parlow, J.J., Burney, M.W., Case, B.L., Girard, T.J., Hall, K.A., Harris, P.K., Hiebsch, R.R., Huff, R.M., Lachance, R.M., Mischke, D.A., Rapp, S.R., Woerndle, R.S., Ennis, M.D. J. Med. Chem. (2010) [Pubmed]
  2. Part II: piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation. Parlow, J.J., Burney, M.W., Case, B.L., Girard, T.J., Hall, K.A., Harris, P.K., Hiebsch, R.R., Huff, R.M., Lachance, R.M., Mischke, D.A., Rapp, S.R., Woerndle, R.S., Ennis, M.D. Bioorg. Med. Chem. Lett. (2010) [Pubmed]
  3. Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation. Parlow, J.J., Burney, M.W., Case, B.L., Girard, T.J., Hall, K.A., Hiebsch, R.R., Huff, R.M., Lachance, R.M., Mischke, D.A., Rapp, S.R., Woerndle, R.S., Ennis, M.D. Bioorg. Med. Chem. Lett. (2009) [Pubmed]
  4. Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation. Parlow, J.J., Burney, M.W., Case, B.L., Girard, T.J., Hall, K.A., Hiebsch, R.R., Huff, R.M., Lachance, R.M., Mischke, D.A., Rapp, S.R., Woerndle, R.S., Ennis, M.D. Bioorg. Med. Chem. Lett. (2009) [Pubmed]
  5. Polymer-assisted solution-phase chemical library synthesis. Parlow, J.J. Curr. Opin. Drug. Discov. Devel (2005) [Pubmed]
  6. Polymer-assisted solution-phase library synthesis and crystal structure of alpha-ketothiazoles as tissue factor VIIa inhibitors. Parlow, J.J., Dice, T.A., Lachance, R.M., Girard, T.J., Stevens, A.M., Stegeman, R.A., Stallings, W.C., Kurumbail, R.G., South, M.S. J. Med. Chem. (2003) [Pubmed]
  7. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex. Parlow, J.J., Case, B.L., Dice, T.A., Fenton, R.L., Hayes, M.J., Jones, D.E., Neumann, W.L., Wood, R.S., Lachance, R.M., Girard, T.J., Nicholson, N.S., Clare, M., Stegeman, R.A., Stevens, A.M., Stallings, W.C., Kurumbail, R.G., South, M.S. J. Med. Chem. (2003) [Pubmed]
  8. Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors. Parlow, J.J., Stevens, A.M., Stegeman, R.A., Stallings, W.C., Kurumbail, R.G., South, M.S. J. Med. Chem. (2003) [Pubmed]
  9. Synthesis and X-ray crystal structures of substituted fluorobenzene and benzoquinone inhibitors of the tissue factor VIIa complex. Parlow, J.J., Kurumbail, R.G., Stegeman, R.A., Stevens, A.M., Stallings, W.C., South, M.S. Bioorg. Med. Chem. Lett. (2003) [Pubmed]
  10. Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors. Parlow, J.J., Kurumbail, R.G., Stegeman, R.A., Stevens, A.M., Stallings, W.C., South, M.S. J. Med. Chem. (2003) [Pubmed]
 
WikiGenes - Universities